Cognitive and Metabolic Effects of a Probiotic Supplement
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02005003 |
Recruitment Status : Unknown
Verified November 2014 by Jonathan Cedernaes, Uppsala University.
Recruitment status was: Recruiting
First Posted : December 9, 2013
Last Update Posted : November 18, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Dietary Supplements Probiotics Metabolism Food Preferences Microbiota | Behavioral: Inhibitory task Procedure: Blood samples Biological: Feces collection Procedure: Caloric preload Behavioral: Food selection task Behavioral: Memory task Behavioral: Food consumption task | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 20 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | Double (Participant, Investigator) |
Primary Purpose: | Basic Science |
Official Title: | Placebo-controlled Randomized Trial of Cognitive and Metabolic Effects of a Probiotic Supplement |
Study Start Date : | November 2013 |
Estimated Primary Completion Date : | December 2015 |
Estimated Study Completion Date : | December 2015 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Probiotic
Probiotic pills given for 2 weeks, during one of the interventions that the participants is either randomized to as the first or second intervention period. At day 0 and following each intervention period (at week 2 and week 6), participants will be tested using Inhibitory task, Blood samples, Feces collection, Caloric preload, Food selection task, Memory task and Food consumption task.
|
Behavioral: Inhibitory task
Participants perform a binary decision on each presented stimuli. Of the two possible outcomes, participants are instructed to make a motor response (go) for one type, and are to withhold a response (no-go) for the other type. Reaction time and accuracy are measured for each event Procedure: Blood samples Hormone levels will be analyzed from blood samples obtained before and after a caloric preload given at each visit Biological: Feces collection Feces samples will be collected on the morning of each visit, before and after each 2-week intervention period, as well as after each 2-week washout period following each intervention period. Procedure: Caloric preload A caloric preload will be given to participants, following which blood will be taken at 65 minutes later (specified in Blood sampling) following the ingestion of the caloric preload. Behavioral: Food selection task Participants are given the opportunity to write and use a computer program to specify amount and type of food would ideally like to consume Behavioral: Memory task Participants perform short memory tasks on each visit Behavioral: Food consumption task Participants are given a selection of food items to consume on each visit |
Placebo Comparator: Placebo
Placebo pills given for 2 weeks, during one of the interventions that the participants is either randomized to as the first or second intervention period. At day 0 and following each intervention period (at week 2 and week 6), participants will be tested using Inhibitory task, Blood samples, Feces collection, Caloric preload, Food selection task, Memory task and Food consumption task.
|
Behavioral: Inhibitory task
Participants perform a binary decision on each presented stimuli. Of the two possible outcomes, participants are instructed to make a motor response (go) for one type, and are to withhold a response (no-go) for the other type. Reaction time and accuracy are measured for each event Procedure: Blood samples Hormone levels will be analyzed from blood samples obtained before and after a caloric preload given at each visit Biological: Feces collection Feces samples will be collected on the morning of each visit, before and after each 2-week intervention period, as well as after each 2-week washout period following each intervention period. Procedure: Caloric preload A caloric preload will be given to participants, following which blood will be taken at 65 minutes later (specified in Blood sampling) following the ingestion of the caloric preload. Behavioral: Food selection task Participants are given the opportunity to write and use a computer program to specify amount and type of food would ideally like to consume Behavioral: Memory task Participants perform short memory tasks on each visit Behavioral: Food consumption task Participants are given a selection of food items to consume on each visit |
- Memory function [ Time Frame: Change in memory function assessed at baseline (week 0), post-intervention 1 (at week 2), pre intervention 2 (week 6), post intervention 2 (week 8) and post-washout intervention 2 (week 12) ]Memory test to examine the influence of probiotic supplement compared with placebo on memory function (declarative and working memory)
- Glycometabolic regulation [ Time Frame: Change in glycometabolic regulation assessed at baseline (week 0), post-intervention 1 (at week 2), pre intervention 2 (week 6), post intervention 2 (week 8) and post-washout intervention 2 (week 12) ]Glucose, insulin and other hormonal values during fasting and 1 hour following a standardized caloric preload
- Food preferences [ Time Frame: Change in food preferences assessed at baseline (week 0), post-intervention 1 (at week 2), pre intervention 2 (week 6), post intervention 2 (week 8) and post-washout intervention 2 (week 12) ]Will test whether participants food preferences are changed following each intervention, as compared with before each intervention. Test will be written and computer-based.
- Inhibitory task [ Time Frame: Change in inhibitory task performance assessed at baseline (week 0), post-intervention 1 (at week 2), pre intervention 2 (week 6), post intervention 2 (week 8) and post-washout intervention 2 (week 12) ]Participants perform a binary decision on each presented stimuli. Of the two possible outcomes, participants are instructed to make a motor response (go) for one type, and are to withhold a response (no-go) for the other type. Reaction time and accuracy are measured for each event.
- Food consumption task [ Time Frame: Change in food consumption task assessed at baseline (week 0), post-intervention 1 (at week 2), pre intervention 2 (week 6), post intervention 2 (week 8) and post-washout intervention 2 (week 12) ]Participants will be offered a food selection and their consumption will be measured.
- Sleep patterns [ Time Frame: Change in sleep patterns as assessed at baseline (week 0), post-intervention 1 (at week 2), pre intervention 2 (week 6), post intervention 2 (week 8) and post-washout intervention 2 (week 12) ]
- Microbiome changes [ Time Frame: Microbiome assessed at baseline (week 0), post-intervention 1 (at week 2), pre intervention 2 (week 6), post intervention 2 (week 8) and post-washout intervention 2 (week 12) ]Changes in microbiome will be assessed following treatment with either placebo or probiotics; feces will be collected according to standardized criteria.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 28 Years (Adult) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Male
- Age 18-28y
- Healthy (self-reported) and not on medication
- Non-smoking
- Normal sleep-wake rhythm (i.e. 7-8 h per night, self-reported via diaries)
- Regular meal patterns with daily breakfast
Exclusion Criteria:
- Major illness
- Taking any serious medications
- Any sleep conditions (e.g. irregular bedtimes, sleep complaints)
- Any dietary issues with the food items provided
- Current or history of endocrine, neurological or psychiatric disorders
- Shift work in the preceding three months or for a long duration
- Time travel over a significant number of time zones in the preceding two months
- Too much weight gain or weight loss in the preceding three months
- Excessive intake of fermented dairy products
- Intake of probiotics
- Recent antibiotic treatment (last 6 months)
- Recent intake of certain dietary supplements
- Excessive caffeine (>5 cups daily) or alcohol intake (>2 alcohol units daily)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02005003
Contact: Jonathan Cedernaes, M.D., PhD | jonathan.cedernaes@neuro.uu.se | ||
Contact: Christian Benedict, PhD | christian.benedict@neuro.uu.se |
Sweden | |
Department of Neuroscience, Uppsala University | Recruiting |
Uppsala, Sweden, 75324 | |
Contact: Jonathan Cedernaes, M.D., PhD jonathan.cedernaes@neuro.uu.se | |
Contact: Christian Benedict, PhD christian.benedict@neuro.uu.se | |
Principal Investigator: Christian Benedict, PhD |
Principal Investigator: | Christian Benedict, PhD | Department of Neuroscience, Uppsala University |
Responsible Party: | Jonathan Cedernaes, Medical doctor, PhD, Uppsala University |
ClinicalTrials.gov Identifier: | NCT02005003 |
Other Study ID Numbers: |
FF8vsPlaceboJC2013 |
First Posted: | December 9, 2013 Key Record Dates |
Last Update Posted: | November 18, 2014 |
Last Verified: | November 2014 |